בליאומיצין PFI

Country: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

BLEOMYCIN SULFATE

Fáanlegur frá:

MEGAPHARM LTD

ATC númer:

L01DC01

Lyfjaform:

אבקה להכנת תמיסה לזריקה

Samsetning:

BLEOMYCIN SULFATE 15000 IU/VIAL

Stjórnsýsluleið:

לתוך קרום הריאה, תוך-עורקי, תוך-ורידי, תת-עורי, תוך-שרירי, לתוך בקע

Gerð lyfseðils:

מרשם נדרש

Framleitt af:

BAXTER ONCOLOGY GmbH, GERMANY

Meðferðarhópur:

BLEOMYCIN

Lækningarsvæði:

BLEOMYCIN

Ábendingar:

Bleomycin is useful in the management of the following neoplasms: Squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. Well differentiated tumors usually respond better than anaplastic ones.Hodgkin's disease and other malignant lymphomas, including mycosis fungoides. Testicular carcinoma (seminoma and no seminoma) .Malignant effusions of serous cavities (intrapleural and intraperitoneal).Secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. Local treatment of refractory warts. Bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

Leyfisdagur:

2020-09-30